DBTX
Neuberger Berman Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-58,800
| Closed | -$226K | – | 1892 |
|
2023
Q2 | $226K | Buy |
58,800
+43,139
| +275% | +$166K | ﹤0.01% | 1670 |
|
2023
Q1 | $47.3K | Sell |
15,661
-600
| -4% | -$1.81K | ﹤0.01% | 1765 |
|
2022
Q4 | $33.3K | Sell |
16,261
-52,339
| -76% | -$107K | ﹤0.01% | 1748 |
|
2022
Q3 | $237K | Sell |
68,600
-400
| -0.6% | -$1.38K | ﹤0.01% | 1679 |
|
2022
Q2 | $290K | Buy |
69,000
+6,175
| +10% | +$26K | ﹤0.01% | 1648 |
|
2022
Q1 | $191K | Buy |
62,825
+3,255
| +5% | +$9.9K | ﹤0.01% | 1815 |
|
2021
Q4 | $277K | Buy |
59,570
+16,035
| +37% | +$74.6K | ﹤0.01% | 1747 |
|
2021
Q3 | $336K | Buy |
43,535
+185
| +0.4% | +$1.43K | ﹤0.01% | 1561 |
|
2021
Q2 | $373K | Buy |
43,350
+15,350
| +55% | +$132K | ﹤0.01% | 1539 |
|
2021
Q1 | $318K | Buy |
+28,000
| New | +$318K | ﹤0.01% | 1587 |
|